Technology developed at the University of Nebraska Medical Center will provide the groundwork for a new Chinese biotechnology startup company, Bohe Biotech.
In a deal brokered by UNeMed Corp., UNMC's technology transfer office, Bohe Biotech founder Wang Jiang and UNeMed President Michael Dixon signed a licensing agreement in Chengdu, China, according to a news release from UNMC.
Bohe Biotech will pursue commercial uses of a novel derivative of menthol, a common ingredient found in oral hygiene products. UNMC researcher Dr. Dong Wang's new menthol derivative binds to the tooth's surface and then slowly releases the menthol flavoring over time, according to the release.
Bohe Biotech will focus on producing the new menthol derivative as an additive that could be used by companies who produce any number of oral hygiene products. Bohe Biotech will need to perform additional research and testing before gaining regulatory approval in China.
The process could take about four to five years before Chinese consumers see a product on store shelves, UNMC said.